BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 16171862)

  • 1. Expression of PDZ-binding kinase (PBK) is regulated by cell cycle-specific transcription factors E2F and CREB/ATF.
    Nandi AK; Rapoport AP
    Leuk Res; 2006 Apr; 30(4):437-47. PubMed ID: 16171862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuation of DNA damage checkpoint by PBK, a novel mitotic kinase, involves protein-protein interaction with tumor suppressor p53.
    Nandi AK; Ford T; Fleksher D; Neuman B; Rapoport AP
    Biochem Biophys Res Commun; 2007 Jun; 358(1):181-8. PubMed ID: 17482142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ATF1 and CREB trans-activate a cell cycle regulated histone H4 gene at a distal nuclear matrix associated promoter element.
    Guo B; Stein JL; van Wijnen AJ; Stein GS
    Biochemistry; 1997 Nov; 36(47):14447-55. PubMed ID: 9398163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E2F sites in the Op18 promoter are required for high level of expression in the human prostate carcinoma cell line PC-3-M.
    Polzin RG; Benlhabib H; Trepel J; Herrera JE
    Gene; 2004 Oct; 341():209-18. PubMed ID: 15474303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ATF/CREB site is the key element for transcription of the human RNA methyltransferase like 1(RNMTL1) gene, a newly discovered 17p13.3 gene.
    Xu J; De Zhu J; Ni M; Wan F; Gu JR
    Cell Res; 2002 Sep; 12(3-4):177-97. PubMed ID: 12296377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of adenovirus 12 E1A transcription: E2F and ATF motifs in the E1A promoter bind nuclear protein complexes including E2F1, DP-1, cyclin A and/or RB and mediate transcriptional (auto)activation.
    Kirch HC; PĆ¼tzer B; Schwabe G; Gnauck HK; Schulte Holthausen H
    Cell Mol Biol Res; 1993; 39(8):705-16. PubMed ID: 7951410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CREB Cooperates with BMP-stimulated Smad signaling to enhance transcription of the Smad6 promoter.
    Ionescu AM; Drissi H; Schwarz EM; Kato M; Puzas JE; McCance DJ; Rosier RN; Zuscik MJ; O'Keefe RJ
    J Cell Physiol; 2004 Mar; 198(3):428-40. PubMed ID: 14755548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a second ATF/CREB-like element in the herpes simplex virus type 1 (HSV-1) latency-associated transcript (LAT) promoter.
    Kenny JJ; Krebs FC; Hartle HT; Gartner AE; Chatton B; Leiden JM; Hoeffler JP; Weber PC; Wigdahl B
    Virology; 1994 Apr; 200(1):220-35. PubMed ID: 8128624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late induction of CREB/ATF binding and a concomitant increase in cAMP levels in T and B lymphocytes stimulated via the antigen receptor.
    Feuerstein N; Firestein R; Aiyar N; He X; Murasko D; Cristofalo V
    J Immunol; 1996 Jun; 156(12):4582-93. PubMed ID: 8648100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and characterization of the human Cdc2l2 gene promoter.
    Feng Y; Goulet AC; Nelson MA
    Gene; 2004 Apr; 330():75-84. PubMed ID: 15087126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Pur alpha and E2F-1 suppresses transcriptional activity of E2F-1.
    Darbinian N; Gallia GL; Kundu M; Shcherbik N; Tretiakova A; Giordano A; Khalili K
    Oncogene; 1999 Nov; 18(46):6398-402. PubMed ID: 10597240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-10 induced activating transcription factor 3 transcriptional suppression of matrix metalloproteinase-2 gene expression in human prostate CPTX-1532 Cells.
    Stearns ME; Kim G; Garcia F; Wang M
    Mol Cancer Res; 2004 Jul; 2(7):403-16. PubMed ID: 15280448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional regulation of tumor suppressor p53 by cAMP-responsive element-binding protein/AMP-activated protein kinase complex in response to glucose deprivation.
    Okoshi R; Ando K; Suenaga Y; Sang M; Kubo N; Kizaki H; Nakagawara A; Ozaki T
    Genes Cells; 2009 Dec; 14(12):1429-40. PubMed ID: 19930465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of the cyclin A promoter in differentiating human embryonal carcinoma cells is mediated by depletion of ATF-1 and ATF-2 in the complex at the ATF/CRE site.
    Nakamura T; Okuyama S; Okamoto S; Nakajima T; Sekiya S; Oda K
    Exp Cell Res; 1995 Feb; 216(2):422-30. PubMed ID: 7843287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of the preprotachykinin-I gene promoter through a protein kinase A-dependent, cyclic AMP response element-binding protein-independent mechanism.
    Calin-Jageman IE; Wang J; Bannon MJ
    J Neurochem; 2006 Apr; 97(1):255-64. PubMed ID: 16515544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell cycle-dependent regulation of the human aurora B promoter.
    Kimura M; Uchida C; Takano Y; Kitagawa M; Okano Y
    Biochem Biophys Res Commun; 2004 Apr; 316(3):930-6. PubMed ID: 15033491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
    Zhou D; Masri S; Ye JJ; Chen S
    Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct recruitment of E2F family members to specific E2F-binding sites mediates activation and repression of the E2F1 promoter.
    Araki K; Nakajima Y; Eto K; Ikeda MA
    Oncogene; 2003 Oct; 22(48):7632-41. PubMed ID: 14576826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. U5 region of the human immunodeficiency virus type 1 long terminal repeat contains TRE-like cAMP-responsive elements that bind both AP-1 and CREB/ATF proteins.
    Rabbi MF; Saifuddin M; Gu DS; Kagnoff MF; Roebuck KA
    Virology; 1997 Jun; 233(1):235-45. PubMed ID: 9201233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterisation of regulatory sequences at the Epstein-Barr virus BamHI W promoter.
    Bell A; Skinner J; Kirby H; Rickinson A
    Virology; 1998 Dec; 252(1):149-61. PubMed ID: 9875325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.